The noradrenergic agent reboxetine plus antimuscarinic hyoscin | MedNewsToday

The noradrenergic agent reboxetine plus antimuscarinic hyoscine butylbromide reduces sleep #apnoea severity: A double-blind, placebo-controlled, randomised crossover trial

https://2medical.news/2021/07/18/the-noradrenergic-agent-reboxetine-plus-antimuscarinic-hyoscine-butylbromide-reduces-sleep-apnoea-severity-a-double-blind-placebo-controlled-randomised-crossover-trial/